Cargando…

Development and validation of an m6A RNA methylation regulator-based signature for the prediction of prognosis and immunotherapy in cutaneous melanoma

Detalles Bibliográficos
Autores principales:	Li, Tingting, Zhang, Xiaoyue, Wang, Caroline, Jia, Qiuyu, Zhong, Lingzhi, Hu, Jian, Li, Houmin, Zhang, Jianzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617823/ https://www.ncbi.nlm.nih.gov/pubmed/37036897 http://dx.doi.org/10.1097/CM9.0000000000002599

Ejemplares similares

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Identification and Validation of Ferroptosis-Related DNA Methylation Signature for Predicting the Prognosis and Guiding the Treatment in Cutaneous Melanoma
por: Guo, Wenna, et al.
Publicado: (2022)

Cutaneous Metastasis from Lung Adenocarcinoma
por: Zhong, Lingzhi, et al.
Publicado: (2022)

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to Immunotherapy
por: Xu, Ziqian, et al.
Publicado: (2021)

The development and experimental validation of hypoxia-related long noncoding RNAs prognostic signature in predicting prognosis and immunotherapy of cutaneous melanoma
por: Wang, Gang, et al.
Publicado: (2023)

Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning
por: Zhao, Yi, et al.
Publicado: (2023)

Senescence-Related lncRNA Signature Predicts Prognosis, Response to Immunotherapy and Chemotherapy in Skin Cutaneous Melanoma
por: Lin, Kefan, et al.
Publicado: (2023)

Interpretations about gender in the epidemiology of cutaneous melanoma()
por: Miola, Anna Carolina, et al.
Publicado: (2022)

FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma
por: Wu, Shaobo, et al.
Publicado: (2022)

Primary Cutaneous Extranodal Natural Killer (NK) T-Cell Lymphoma: A Case Report
por: Zhang, Si, et al.
Publicado: (2023)

Development and validation of m6A RNA methylation regulators-based signature in lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2021)

m5C-Related Signatures for Predicting Prognosis in Cutaneous Melanoma with Machine Learning
por: Huang, Maoxin, et al.
Publicado: (2021)

Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma
por: Xie, Ran, et al.
Publicado: (2020)

Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
por: Xing, Jiahua, et al.
Publicado: (2022)

Prediction of clinical prognosis in cutaneous melanoma using an immune-related gene pair signature
por: Yang, Yu, et al.
Publicado: (2021)

Leveraging a cuproptosis-based signature to predict the prognosis and drug sensitivity of cutaneous melanoma
por: Liu, Da, et al.
Publicado: (2023)

Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
por: Leng, Shaolong, et al.
Publicado: (2023)

A novel pyroptosis-associated gene signature for immune status and prognosis of cutaneous melanoma
por: Wu, Zhengyuan, et al.
Publicado: (2021)

Core immune cell infiltration signatures identify molecular subtypes and promote precise checkpoint immunotherapy in cutaneous melanoma
por: Zhu, Zheng, et al.
Publicado: (2022)

The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma
por: Song, Le-Bin, et al.
Publicado: (2021)

Fine particulate matter 2.5 upregulates melanogenesis in A375 human melanoma cells
por: Peng, Fen, et al.
Publicado: (2022)

A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma
por: Xie, Yihui, et al.
Publicado: (2022)

Anthropometry in the immunotherapy of cutaneous and ocular melanomas
por: Săftescu, Sorin, et al.
Publicado: (2020)

Cutaneous melanoma and the immunotherapy revolution (Review)
por: Leonardi, Giulia C., et al.
Publicado: (2020)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Differential DNA methylation in allergen-specific immunotherapy of asthma
por: Wang, Chuang-Ming, et al.
Publicado: (2020)

Development of anoikis-related long non-coding RNA signature associated with prognosis and immune landscape in cutaneous melanoma patients
por: Zhong, Like, et al.
Publicado: (2023)

Comment on “Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy”
por: De Giorgi, Vincenzo, et al.
Publicado: (2019)

Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer
por: Zhang, Yichi, et al.
Publicado: (2022)

A Novel Pyroptosis-Related lncRNA Signature for Predicting the Prognosis of Skin Cutaneous Melanoma
por: Xie, Jiaheng, et al.
Publicado: (2021)

Gene signature from cutaneous autoimmune diseases provides potential immunotherapy-relevant biomarkers in melanoma
por: Chun, Kyu-Hye, et al.
Publicado: (2023)

A Novel Necroptosis-Related Gene Signature in Skin Cutaneous Melanoma Prognosis and Tumor Microenvironment
por: Song, Binyu, et al.
Publicado: (2022)

Granzyme family acts as a predict biomarker in cutaneous melanoma and indicates more benefit from anti-PD-1 immunotherapy
por: Wu, Xia, et al.
Publicado: (2021)

Reply to Comment on “Improving clinical diagnosis of early-stage cutaneous melanoma based on Raman spectroscopy”
por: Santos, Inês P., et al.
Publicado: (2019)

Identification and validation of a ferroptosis‐related gene signature for predicting survival in skin cutaneous melanoma
por: Ping, Shuai, et al.
Publicado: (2022)

A novel inflammatory response-related signature predicts the prognosis of cutaneous melanoma and the effect of antitumor drugs
por: Xing, Jiahua, et al.
Publicado: (2022)

Construction and validation of a novel prognostic signature for cutaneous melanoma based on ferroptosis-related genes
por: Guo, Wenna, et al.
Publicado: (2023)

Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma
por: Li, An-An, et al.
Publicado: (2022)

Nanomedicine to modulate immunotherapy in cutaneous melanoma (Review)
por: Volovat, Simona Ruxandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8avdko4dbovdr6hlkh2e874ej7